Learning Objectives

1) Appreciate the high variability in hydroxychloroquine (HCQ) pharmacokinetics

2) Understand the relationship between HCQ exposure and response

3) Appreciate the impact of medication non-adherence on HCQ exposure

Disclosures: 

Stephen Balevic receives support from the National Institutes of Health (5R01-HD076676-

04, HHSN275201000003I, HHSN275201800003I, 5U24-TR001608-03), PCORI, the

Rheumatology Research Foundation’s Scientist Development Award, the Thrasher

Research Fund, the Childhood Arthritis and Rheumatology Research Alliance, and

consulting for UCB.

CME Code: WEPYAL

Location: virtual only (by WebEx)
Directions: see attachment (PDF) in prior email on How to Download WebEx

Streaming: Yes, via WebEx.  Link:  Click to Join

[Meeting Number (Access Code): 738 886 371 > you will not need this if you use link above]